Oxford Industries Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Oxford Industries Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2024-02-01 | 2023-02-03 | 2022-01-28 | 2021-01-29 | 2020-01-30 | 2019-02-01 | 2018-02-02 | 2017-02-03 | 2016-01-28 | 2015-01-30 | 2014-01-31 | 2008-08-02 | 2008-05-03 | 2005-09-02 | 2004-11-26 | 2004-08-27 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||
net earnings | -27,800,000 | 25,333,000 | 22,635,000 | 39,370,000 | 598,000 | 15,440,000 | 1,473,000 | 9,517,000 | 13,883,000 | 9,072,000 | 6,168,000 | |||||
adjustments to reconcile net earnings to cash flows from operating activities: | ||||||||||||||||
depreciation | 20,396,000 | 10,101,000 | 10,928,000 | 14,631,000 | 8,595,000 | 11,739,000 | 5,197,000 | 4,786,000 | 3,537,000 | 3,268,000 | 3,037,000 | |||||
amortization of intangible assets | 997,000 | 877,000 | 660,000 | 660,000 | 68,000 | 1,186,000 | 4,058,000 | 788,000 | 1,853,000 | 2,424,000 | 1,712,000 | |||||
equity compensation expense | 5,640,000 | 2,711,000 | 1,081,000 | 2,687,000 | 2,393,000 | |||||||||||
amortization and write-off of deferred financing costs | -80,000 | |||||||||||||||
deferred income taxes | -2,623,000 | -449,000 | -4,191,000 | 8,647,000 | 269,000 | -7,295,000 | -999,000 | -597,000 | -1,820,000 | -1,158,000 | -2,175,000 | |||||
changes in operating assets and liabilities, net of acquisitions and dispositions: | ||||||||||||||||
receivables | 3,997,000 | 15,667,000 | -6,066,000 | -3,629,000 | 16,748,000 | 2,705,000 | 26,349,000 | -17,366,000 | -2,983,000 | -15,418,000 | 40,659,000 | |||||
inventories | -69,835,000 | -53,535,000 | 9,386,000 | 3,414,000 | -5,138,000 | 2,935,000 | -7,350,000 | 36,257,000 | 945,000 | -17,880,000 | -823,000 | |||||
income tax receivable | 14,239,000 | |||||||||||||||
prepaid expenses and other current assets | 13,092,000 | |||||||||||||||
current liabilities | 63,991,000 | 19,298,000 | 34,516,000 | 11,505,000 | 9,531,000 | 31,043,000 | -731,000 | -2,515,000 | ||||||||
other balance sheet changes | ||||||||||||||||
cash from operating activities | 24,634,000 | 158,029,000 | -31,475,000 | 175,329,000 | 8,644,000 | 57,308,000 | 31,099,000 | |||||||||
capex | -79,735,000 | 0 | 0 | 0 | 0 | 0 | -10,686,000 | |||||||||
free cash flows | -55,101,000 | 158,029,000 | -31,475,000 | 175,329,000 | 8,644,000 | 57,308,000 | 20,413,000 | |||||||||
cash flows from investing activities: | ||||||||||||||||
acquisitions, net of cash acquired | -4,368,000 | 4,701,000 | 76,431,000 | |||||||||||||
purchases of property and equipment | -79,735,000 | -10,686,000 | 1,396,000 | 13,802,000 | -36,533,000 | -13,612,000 | ||||||||||
other investing activities | -1,318,000 | |||||||||||||||
cash from investing activities | -87,546,000 | 45,719,000 | 10,799,000 | -156,656,000 | -7,774,000 | -6,153,000 | -5,985,000 | |||||||||
cash flows from financing activities: | ||||||||||||||||
repayment of revolving credit arrangements | -32,421,000 | -90,761,000 | 44,234,000 | -158,042,000 | -101,243,000 | -126,602,000 | ||||||||||
proceeds from revolving credit arrangements | 87,013,000 | 77,323,000 | -188,385,000 | 244,478,000 | 31,514,000 | 44,052,000 | ||||||||||
repurchase of common stock | ||||||||||||||||
proceeds from issuance of common stock | 343,000 | 385,000 | 666,000 | |||||||||||||
repurchase of equity awards for employee tax withholding liabilities | 3,742,000 | |||||||||||||||
cash dividends paid | -11,744,000 | |||||||||||||||
other financing activities | ||||||||||||||||
cash from financing activities | -174,332,000 | 11,608,000 | -40,986,000 | -816,000 | -9,233,000 | -22,611,000 | ||||||||||
net change in cash and cash equivalents | 2,897,000 | 29,416,000 | -9,068,000 | -22,313,000 | 54,000 | 41,922,000 | 2,503,000 | 875,000 | -1,305,000 | 1,820,000 | -4,530,000 | -1,364,000 | -8,617,000 | 634,000 | 7,444,000 | -36,010,000 |
effect of foreign currency translation on cash and cash equivalents | -84,000 | -264,000 | 108,000 | 37,000 | 1,430,000 | -465,000 | 512,000 | -200,000 | -109,000 | 444,000 | -33,000 | |||||
cash and cash equivalents at the beginning of year | -1,222,000 | 11,000 | 9,000 | 1,042,000 | -3,202,000 | 966,000 | 47,569,000 | |||||||||
cash and cash equivalents at the end of period | 1,591,000 | -852,000 | 6,095,000 | 7,024,000 | 7,888,000 | 11,526,000 | ||||||||||
gain on sale of property and equipment | ||||||||||||||||
proceeds from the sale of property, plant and equipment | ||||||||||||||||
deferred financing costs paid | ||||||||||||||||
impairment of goodwill, intangible assets and equity method investments | ||||||||||||||||
impairment of property and equipment | ||||||||||||||||
impairment of operating lease assets | ||||||||||||||||
other non-current assets | 75,000 | -2,679,000 | 1,624,000 | 621,000 | 2,029,000 | 41,000 | -996,000 | |||||||||
other non-current liabilities | 386,000 | -9,709,000 | 7,466,000 | 1,171,000 | -1,480,000 | 3,303,000 | 2,168,000 | |||||||||
purchases of short-term investments | ||||||||||||||||
proceeds from short-term investments | ||||||||||||||||
gain on sale of assets | ||||||||||||||||
cash from (provided by) financing activities | ||||||||||||||||
gain on sale of investment in unconsolidated entity | ||||||||||||||||
amortization of deferred financing costs | 107,000 | -155,000 | 404,000 | 97,000 | ||||||||||||
change in fair value of contingent consideration | 69,000 | |||||||||||||||
proceeds from sale of investment in unconsolidated entity | ||||||||||||||||
impairment of goodwill and intangible assets | ||||||||||||||||
cash dividends declared and paid | -9,413,000 | -4,598,000 | ||||||||||||||
deferred income taxes (benefit) expense | ||||||||||||||||
cash and cash equivalents at the end of the period | ||||||||||||||||
adjustments to reconcile net earnings to net cash from operating activities: | ||||||||||||||||
effect of changes in operating assets and liabilities, net of acquisitions and dispositions: | ||||||||||||||||
changes in working capital, net of acquisitions and dispositions: | ||||||||||||||||
supplemental disclosure of cash flow information: | ||||||||||||||||
cash paid for interest | 10,000 | 706,000 | 768,000 | -236,000 | 529,000 | |||||||||||
cash paid for income taxes | -5,927,000 | -5,450,000 | -2,269,000 | -2,289,000 | 25,382,000 | |||||||||||
adjustments to reconcile net earnings to cash from operating activities: | ||||||||||||||||
changes in working capital, net of acquisitions and dispositions, if any: | ||||||||||||||||
repurchase of stock awards for employee tax withholding liabilities | ||||||||||||||||
cash and cash equivalents at the end of year | ||||||||||||||||
prepaid expenses | -3,969,000 | 5,089,000 | 2,983,000 | 5,825,000 | -4,434,000 | 879,000 | -2,860,000 | 231,000 | 1,669,000 | |||||||
loss on sale of discontinued operations | ||||||||||||||||
(payments for) proceeds from sale of discontinued operations | ||||||||||||||||
payment of contingent consideration amounts earned | ||||||||||||||||
net cash from operating activities | 25,898,000 | 36,246,000 | -18,576,000 | 2,616,000 | 12,092,000 | |||||||||||
(working capital settlement) proceeds from sale related to discontinued operations | ||||||||||||||||
net cash from investing activities | -3,778,000 | -8,944,000 | -8,510,000 | -4,789,000 | -141,713,000 | |||||||||||
proceeds from issuance of common stock, net of equity awards withheld for taxes | ||||||||||||||||
net cash from financing activities | -23,484,000 | -35,919,000 | 27,720,000 | 9,617,000 | 93,611,000 | |||||||||||
working capital settlement related to sale of discontinued operations | ||||||||||||||||
proceeds from sale of discontinued operations | -61,366,000 | |||||||||||||||
investment in unconsolidated entity | -222,000 | |||||||||||||||
payment of contingent consideration | ||||||||||||||||
proceeds from issuance of common stock, including excess tax benefits | 495,000 | -6,186,000 | ||||||||||||||
dividends paid | ||||||||||||||||
excess tax benefits related to equity-based compensation | ||||||||||||||||
amortization of deferred financing costs and bond discount | 62,000 | 653,000 | 654,000 | 616,000 | 659,000 | 2,459,000 | ||||||||||
loss on repurchase of senior notes | ||||||||||||||||
stock compensation expense | 2,553,000 | 1,028,000 | 639,000 | |||||||||||||
excess tax benefits related to stock-based compensation | ||||||||||||||||
proceeds from sale of property and equipment | ||||||||||||||||
repurchase of senior notes | ||||||||||||||||
repurchase of restricted stock for employee tax withholding liabilities | ||||||||||||||||
dividends on common stock | -5,812,000 | -2,889,000 | -1,946,000 | |||||||||||||
cash paid (refunded) for income taxes | ||||||||||||||||
earnings from continuing operations | ||||||||||||||||
adjustments to reconcile earnings from continuing operations to net cash from operating activities: | ||||||||||||||||
cash flows from discontinued operations: | ||||||||||||||||
net cash from discontinued operations | ||||||||||||||||
oxford industries, inc. consolidated statements of cash flows | ||||||||||||||||
changes in working capital: | ||||||||||||||||
cash paid for interest, net, including interest paid for discontinued operations | ||||||||||||||||
cash paid (refunded) for income taxes, including income taxes paid for discontinued operations | ||||||||||||||||
loss on repurchase of 113/8% senior secured notes | ||||||||||||||||
loss on sale of property and equipment | ||||||||||||||||
other | ||||||||||||||||
repurchase of 113/8% senior secured notes | ||||||||||||||||
net operating cash flows used in discontinued operations | ||||||||||||||||
net investing cash flows from discontinued operations | ||||||||||||||||
cash paid for income taxes, including income taxes paid for discontinued operations | ||||||||||||||||
amortization/write-off of deferred financing costs and bond discount | ||||||||||||||||
net operating cash flows from discontinued operations | ||||||||||||||||
net investing cash flows used in discontinued operations | ||||||||||||||||
adjustments to reconcile net earnings from continuing operations to net cash from operating activities: | ||||||||||||||||
loss on sale of property, plant and equipment | ||||||||||||||||
purchases of property, plant and equipment | -3,558,000 | -8,722,000 | -3,473,000 | -4,020,000 | -2,488,000 | |||||||||||
proceeds from sale of property, plant and equipment | 6,000 | 403,000 | 10,000 | |||||||||||||
repayment of company-owned life insurance policy loans | ||||||||||||||||
repurchase of 8 7/8% senior unsecured notes | ||||||||||||||||
proceeds from the issuance of 11 3/8% senior secured notes | ||||||||||||||||
(gain) loss on sale of property, plant and equipment | ||||||||||||||||
equity method investment income | ||||||||||||||||
investments in unconsolidated entities | ||||||||||||||||
repayment of financing arrangements | -85,642,000 | -76,228,000 | -73,971,000 | |||||||||||||
proceeds from financing arrangements | 68,174,000 | 42,941,000 | 101,920,000 | |||||||||||||
net earnings from continuing operations | ||||||||||||||||
loss on sale of property, plant and equipment and impairment loss | ||||||||||||||||
equity loss (income) from unconsolidated entities | -5,000 | -324,000 | ||||||||||||||
proceeds from issuance of common stock including tax benefits | -204,000 | 257,000 | ||||||||||||||
cash and cash equivalents at the beginning of period | 0 | 14,912,000 | 6,499,000 | |||||||||||||
equity income from unconsolidated entities | ||||||||||||||||
acquisitions, net of cash acquired, and investment in unconsolidated entity | ||||||||||||||||
gain on sale of property, plant and equipment | 110,000 | 184,000 | ||||||||||||||
impairment of goodwill, intangible assets and joint venture investment | ||||||||||||||||
gain on repurchase of senior unsecured notes | ||||||||||||||||
equity method investment (income) loss | ||||||||||||||||
stock option income tax benefit | ||||||||||||||||
acquisitions, net of cash acquired, and investments in unconsolidated entities | ||||||||||||||||
distributions from unconsolidated entities | ||||||||||||||||
repurchase of senior unsecured notes | ||||||||||||||||
supplemental disclosure of non-cash investing and financing activities: | ||||||||||||||||
accrual for additional acquisition cost | ||||||||||||||||
distribution from unconsolidated entity | ||||||||||||||||
equity (income) loss | ||||||||||||||||
net financing cash flows used in discontinued operations | ||||||||||||||||
cash flows from operating activities | ||||||||||||||||
(gain) on the sale of assets | ||||||||||||||||
equity income | -164,000 | 0 | -323,000 | |||||||||||||
trade accounts payable | -20,789,000 | 11,670,000 | -21,022,000 | |||||||||||||
accrued expenses and other current liabilities | -10,091,000 | 12,600,000 | -21,488,000 | |||||||||||||
stock options income tax benefit | 1,128,000 | 378,000 | 587,000 | |||||||||||||
income taxes payable | -3,010,000 | -3,872,000 | 1,020,000 | |||||||||||||
cash flows from investing activities | ||||||||||||||||
distribution from joint venture investment | 1,856,000 | |||||||||||||||
investment in deferred compensation plan | -330,000 | -984,000 | 391,000 | |||||||||||||
net cash (used in) investing activities | ||||||||||||||||
cash flows from financing activities | ||||||||||||||||
payments of debt issuance costs | 0 | -2,766,000 | ||||||||||||||
proceeds from issuance of common shares | 2,049,000 | |||||||||||||||
dividends on common shares | -2,278,000 | |||||||||||||||
supplemental cash flow information: | ||||||||||||||||
cash paid for: | ||||||||||||||||
interest | 2,574,000 | |||||||||||||||
income taxes | 11,466,000 | |||||||||||||||
equity loss | ||||||||||||||||
contribution to joint venture investment | ||||||||||||||||
decrease in restricted cash in escrow | ||||||||||||||||
net investing cash flows (provided by) used in discontinued operations | ||||||||||||||||
gain on the sale of assets | 7,000 | -454,000 | 348,000 | |||||||||||||
accounts payable, accrued expenses and other current liabilities | ||||||||||||||||
acquisition, net of cash acquired | -6,569,000 | -188,000 | -139,626,000 | |||||||||||||
acquisition — net of cash acquired | ||||||||||||||||
decrease (increase) in restricted cash in escrow | ||||||||||||||||
supplemental schedule of non-cash investing and financing activities: | ||||||||||||||||
supplemental disclosure of cash flow information | ||||||||||||||||
other noncurrent assets | 229,000 | -1,410,000 | ||||||||||||||
other noncurrent liabilities | 867,000 | 1,674,000 | ||||||||||||||
decrease in restricted cash | ||||||||||||||||
payments of short-term debt | ||||||||||||||||
proceeds from (payments of) long-term debt | ||||||||||||||||
dividends paid on common shares | ||||||||||||||||
proceeds from short-term debt | 97,592,000 | |||||||||||||||
payments of long-term debt | 65,000 | |||||||||||||||
other non current liabilities | ||||||||||||||||
long-term debt repayments | ||||||||||||||||
proceeds from issuance of notes | ||||||||||||||||
note issue costs |
We provide you with 20 years of cash flow statements for Oxford Industries stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Oxford Industries stock. Explore the full financial landscape of Oxford Industries stock with our expertly curated income statements.
The information provided in this report about Oxford Industries stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.